World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Molecular Biology 105 440 400 40 36 297 55545

Christof von Kalle publications per year

The chart shows the history of publications by Christof von Kalle between 1992 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Christof von Kalle published across 35 years, from 1992 to 2026, averaging 11 papers a year. Output peaked at 45 publications in 2023. 4 of the 386 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1992 to 2026. Vertical axis: number of publications, 0 to 45. Peak 45 publications in 2023. 1992: 3 publications 1993: 1 publication 1994: 0 publications 1995: 2 publications 1996: 1 publication 1997: 2 publications 1998: 2 publications 1999: 0 publications 2000: 1 publication 2001: 0 publications 2002: 5 publications 2003: 8 publications 2004: 7 publications 2005: 9 publications 2006: 16 publications 2007: 8 publications 2008: 8 publications 2009: 7 publications 2010: 13 publications 2011: 19 publications 2012: 16 publications 2013: 22 publications 2014: 21 publications 2015: 23 publications 2016: 14 publications 2017: 19 publications 2018: 20 publications 2019: 19 publications 2020: 25 publications 2021: 29 publications 2022: 11 publications 2023: 45 publications 2024: 6 publications 2025: 3 publications 2026: 1 publication
1992 2026

386 publications in total across all disciplines

View publications per year as a table
Christof von Kalle: publications per year, 1992 to 2026
Year Publications
1992 3
1993 1
1994 0
1995 2
1996 1
1997 2
1998 2
1999 0
2000 1
2001 0
2002 5
2003 8
2004 7
2005 9
2006 16
2007 8
2008 8
2009 7
2010 13
2011 19
2012 16
2013 22
2014 21
2015 23
2016 14
2017 19
2018 20
2019 19
2020 25
2021 29
2022 11
2023 45
2024 6
2025 3
2026 1
Total 386
Download as CSV

Christof von Kalle publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Christof von Kalle sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 53 bars. Horizontal axis: publications, 47–56 to 564+. Vertical axis: number of scientists, 0 to 177. Most scientists, 177, have 117–126 publications. The last bar groups every scientist with 564 publications or more. The highlighted bar, 297–306 publications, is where this scientist sits. 47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47–56 publications 564+

This scientist: 297 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

View publications distribution as a table
Number of Molecular Biology scientists by publication count, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
Publications Scientists This scientist
47–56 7
57–66 17
67–76 65
77–86 90
87–96 125
97–106 131
107–116 162
117–126 177
127–136 158
137–146 158
147–156 146
157–166 159
167–176 131
177–186 110
187–196 112
197–206 100
207–216 89
217–226 98
227–236 74
237–246 72
247–256 63
257–266 53
267–276 54
277–286 49
287–296 52
297–306 43 297
307–316 46
317–326 41
327–336 42
337–346 31
347–356 28
357–366 29
367–376 26
377–386 24
387–396 24
397–406 14
407–416 13
417–426 20
427–436 12
437–446 20
447–456 11
457–466 10
467–476 14
477–486 14
487–496 10
497–506 13
507–516 13
517–526 2
527–536 4
537–546 6
547–556 8
557–563 6
564+ 100
Download as CSV

Christof von Kalle D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Christof von Kalle sits on this spectrum.

No. of scientists
25 50 75 100 125
Bar chart with 54 bars. Horizontal axis: D-Index, 40–41 to 145+. Vertical axis: number of scientists, 0 to 131. Most scientists, 131, have 64–65 D-Index. The last bar groups every scientist with 145 D-Index or more. The highlighted bar, 104–105 D-Index, is where this scientist sits. 40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40–41 D-Index 145+

This scientist: 105 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

View D-Index distribution as a table
Number of Molecular Biology scientists by D-index, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
D-Index Scientists This scientist
40–41 36
42–43 101
44–45 115
46–47 121
48–49 118
50–51 130
52–53 106
54–55 116
56–57 113
58–59 129
60–61 120
62–63 105
64–65 131
66–67 95
68–69 97
70–71 106
72–73 83
74–75 89
76–77 77
78–79 70
80–81 73
82–83 60
84–85 48
86–87 45
88–89 50
90–91 31
92–93 51
94–95 43
96–97 38
98–99 39
100–101 41
102–103 29
104–105 33 105
106–107 35
108–109 20
110–111 38
112–113 19
114–115 28
116–117 13
118–119 23
120–121 16
122–123 15
124–125 11
126–127 21
128–129 7
130–131 13
132–133 14
134–135 17
136–137 9
138–139 8
140–141 16
142–143 7
144 7
145+ 100
Download as CSV

Overview

Christof von Kalle is affiliated with Charité - University Medicine Berlin in Germany. Their research primarily focuses on the field of Medicine, with a particular emphasis on Infectious Diseases, Oncology, Artificial Intelligence, Molecular Biology, and Epidemiology.

The scientist has been involved in topics including:

  • AI in cancer detection
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Cutaneous Melanoma Detection and Management
  • Long-Term Effects of COVID-19
  • Radiomics and Machine Learning in Medical Imaging
  • Cell Image Analysis Techniques

Among their recent papers are:

  • Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment, 2020, Cell
  • COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis, 2020, Nature Biotechnology
  • Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection, 2020, Cell Systems
  • Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study, 2021, The Lancet Respiratory Medicine
  • Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers, 2021, Cancer Discovery

The scientist frequently collaborates with colleagues including Titus J. Brinker, Florian Kurth, Leif Erik Sander, Eva Krieghoff-Henning, and Stefan Fröhling.

Key publication venues where Christof von Kalle has contributed significantly include:

  • European Journal of Cancer
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Infection
  • Annals of Oncology
  • Leukemia

Best Publications

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency

    Salima Hacein-Bey-Abina;Christof Von Kalle;Manfred Schmidt;Françoise Le Deist

  • International network of cancer genome projects

    Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker

  • Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy

    Nathalie Cartier;Salima Hacein-Bey-Abina;Cynthia C. Bartholomae;Gabor Veres

  • The landscape of genomic alterations across childhood cancers

    Susanne N. Gröbner;Barbara C. Worst;Joachim Weischenfeldt;Joachim Weischenfeldt;Ivo Buchhalter

  • Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients

    Steven J. Howe;Marc R. Mansour;Kerstin Schwarzwaelder;Cynthia Bartholomae

  • Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.

    Jonas Schulte-Schrepping;Nico Reusch;Daniela Paclik;Kevin Baßler

  • Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.

    Alessandra Biffi;Eugenio Montini;Laura Lorioli;Martina Cesani

  • Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

    Marion G Ott;Manfred Schmidt;Kerstin Schwarzwaelder;Stefan Stein

  • Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome

    Alessandro Aiuti;Luca Biasco;Samantha Scaramuzza;Francesca Ferrua

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Dissecting the genomic complexity underlying medulloblastoma

    David T. W. Jones;Natalie Jäger;Marcel Kool;Thomas Zichner

  • Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

    Stefan Stein;Marion G. Ott;Stephan Schultze-Strasser;Anna Jauch

  • Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

    Eugenio Montini;Daniela Cesana;Manfred Schmidt;Francesca Sanvito

  • Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

    H Bobby Gaspar;Kathryn L Parsley;Steven Howe;Doug King

  • Murine leukemia induced by retroviral gene marking.

    Zhixiong Li;Zhixiong Li;Jochen Düllmann;Bernd Schiedlmeier;Manfred Schmidt

  • Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

    David T W Jones;Barbara Hutter;Natalie Jäger;Andrey Korshunov;Andrey Korshunov

  • Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition

    Marcel Kool;David T.W. Jones;Natalie Jäger;Paul A. Northcott

  • An unbiased genome-wide analysis of zinc-finger nuclease specificity

    Richard Gabriel;Angelo Lombardo;Anne Arens;Jeffrey C Miller

Frequent Co-Authors

Manfred Schmidt
Manfred Schmidt German Cancer Research Center
Hanno Glimm
Hanno Glimm TU Dresden
Jochen Utikal
Jochen Utikal German Cancer Research Center
Philippe Leboulch
Philippe Leboulch Brigham and Women's Hospital
Alexander Enk
Alexander Enk Heidelberg University
Adrian J. Thrasher
Adrian J. Thrasher University College London
Manfred Schmidt
Manfred Schmidt Johannes Gutenberg University of Mainz
Dirk Schadendorf
Dirk Schadendorf University of Duisburg-Essen
Roland Eils
Roland Eils Charité - University Medicine Berlin
Benedikt Brors
Benedikt Brors German Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring molecular biology can open doors to various health and science careers, and many students are leveraging online pathways to advance their options. Those with a science background might be interested in a slp bridge program for non-SLP majors, which allows a smooth transition into speech-language pathology roles.

If you’re considering a shift into nursing, earning a nursing degree is more accessible than ever. Online programs like the non nursing degree to bsn online make it possible to become a nurse without a traditional nursing background, providing flexibility and accelerated timelines.

Many molecular biology graduates also pursue advanced healthcare roles. For example, psychiatric nurse practitioners enjoy competitive compensation, which you can explore in detail in the dnp psychiatric nurse practitioner salary guide. If you’re curious about the quickest way to qualify for such positions, check out how to become a nurse practitioner for insights into the shortest educational routes.

Best Scientists Citing Christof von Kalle

Trending Scientists

Recently Published Articles